Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides

Loading...
Thumbnail Image
File version
Version of Record (VoR)
Author(s)
Ray, RM
Hansen, AH
Taskova, M
Jandl, B
Hansen, J
Soemardy, C
Morris, KV
Astakhova, K
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
http://creativecommons.org/licenses/by/4.0/
Abstract

Lipid nanoparticles (LNPs) constitute a facile and scalable approach for delivery of payloads to human cells. LNPs are relatively immunologically inert and can be produced in a cost effective and scalable manner. However, targeting and delivery of LNPs across the blood–brain barrier (BBB) has proven challenging. In an effort to target LNPs composed of an ionizable cationic lipid (DLin-MC3-DMA), cholesterol, the phospholipid 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (DMG-PEG 2000) to particular cell types, as well as to generate LNPs that can cross the BBB, we developed and assessed two approaches. The first was centered on the BBB-penetrating trans-activator of transcription (Tat) peptide or the peptide T7, and the other on RNA aptamers targeted to glycoprotein gp160 from human immunodeficiency virus (HIV) or C-C chemokine receptor type 5 (CCR5), a HIV-1 coreceptor. We report herein a CCR5-selective RNA aptamer that acts to facilitate entry through a simplified BBB model and that drives the uptake of LNPs into CCR5-expressing cells, while the gp160 aptamer did not. We further observed that the addition of cell-penetrating peptides, Tat and T7, did not increase BBB penetration above the aptamer-loaded LNPs alone. Moreover, we found that these targeted LNPs exhibit low immunogenic and low toxic profiles and that targeted LNPs can traverse the BBB to potentially deliver drugs into the target tissue. This approach highlights the usefulness of aptamer-loaded LNPs to increase target cell specificity and potentially deliverability of central-nervous-system-active RNAi therapeutics across the BBB.

Journal Title
Beilstein Journal of Organic Chemistry
Conference Title
Book Title
Edition
Volume
17
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© 2021 Ray et al.; licensee Beilstein-Institut. This is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the author(s) and source are credited and that individual graphics may be subject to special legal provisions. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms) The definitive version of this article is the electronic one which can be found at: https://doi.org/10.3762/bjoc.17.75
Item Access Status
Note
Access the data
Related item(s)
Subject
Organic chemistry
Persistent link to this record
Citation
Ray, RM; Hansen, AH; Taskova, M; Jandl, B; Hansen, J; Soemardy, C; Morris, KV; Astakhova, K, Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides, Beilstein Journal of Organic Chemistry, 2021, 17, pp. 891-907
Collections